HIF-1α regulates the expression of proangiogenic genes, specifically vascular endothelial growth factor and the angiopoietin/Tie-2 system in vitro in primary human endothelial cells [118], thereby, improving tumor blood flow. This evidence concerns the gene HIF1A and neoplasm.